Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Nepeta Menthoides Boiss. & Buhse Freeze-Dried Aqueous Extract Versus Sertraline in the Treatment of Major Depression: A Double Blind Randomized Controlled Trial Publisher Pubmed



Kolouri S1, 2 ; Firoozabadi A3 ; Salehi A1, 2 ; Zarshenas MM4, 5 ; Dastgheib SA6 ; Heydari M1, 2 ; Rezaeizadeh H7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  2. 2. Department of Traditional Persian Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3. Research Center for Psychiatry and Behavioral Sciences, Department of Psychiatry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  4. 4. Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5. Department of Phytopharmaceuticals (Traditional Pharmacy), School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Substance Abuse Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  7. 7. Department of Traditional Persian Medicine, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Complementary Therapies in Medicine Published:2016


Abstract

Background: Depression is the most common psychiatric disorder in the world. The conventional medications for depression, however, often have significant side effects. These adverse effects of conventional therapies, have motivated researchers to study alternative options including complementary and traditional treatments for solving the problem. Objective: To compare the efficacy of Nepeta menthoides Boiss. & Buhse freeze-dried aqueous extract with sertraline in the treatment of major depression. Design and setting: From April to September of 2015, 72 patients from two psychiatry clinics of Shiraz University of Medical Sciences who met the criteria for major depression based on the structured clinical interview as defined by the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, participated in a two-armed double-blind randomized controlled trial. Intervention: Subjects were randomly assigned to receive Nepeta menthoides or sertraline for four weeks. Outcome measures: Patients were evaluated in terms of the Beck Depression Inventory-II (BDI-II) total score and common side effects of medications at the base line, the second and fourth weeks, and two weeks following the intervention (i.e. in the sixth week). Results: The mean changes in the Beck Depression Inventory scores in Nepeta menthoides group were significantly higher in terms of the BDI-II scores diminution as compared to that of the control (p ≤ 0.001). Two weeks follow up after intervention showed a lower recurrence rate in the Nepeta menthoides group (p ≤ 0.001). Conclusion: Nepeta menthoides may have potential benefits in the control of mood in patients suffering from major depression. Sustention of antidepressant effect and delay in the recurrence of depression could be considered worthwhile using this herb. © 2016.
Experts (# of related papers)
Other Related Docs